Dan Haemmerle
Vice President of Finance
Replay available
Quest Diagnostics Incorporated (DGX) Q2 2026 Earnings Call
Quest Diagnostics Incorporated (NYSE: DGX) Q2 2026 earnings conference call, held 2026-07-23. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jim Davis
Chairman, Chief Executive Officer and President
Sam Samad
Chief Financial Officer
Erin Wright
Analyst at Morgan Stanley
Lisa Gill
Analyst at JP Morgan
Michael Cherney
Analyst at Leerink Partners
Michael Ruskin
Analyst at Bank of America
Anne Hines
Analyst at Mizuho Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:05.576 Welcome to the Quest Diagnostics second quarter 2026 conference call. 00:00:05.576 -- 00:00:09.198 At the request of the company, this call is being recorded. 00:00:09.198 -- 00:00:13.662 The entire contents of the call, including the presentation and the question and answer 00:00:13.662 -- 00:00:18.506 session that will follow, are the copyrighted property of Quest Diagnostics with all 00:00:18.506 -- 00:00:24.191 rights reserved. Any redistribution, retransmission, or rebroadcast 00:00:24.191 -- 00:00:29.203 of this call in any form without the written consent of Quest Diagnostics is 00:00:29.203 -- 00:00:31.204 strictly prohibited. 00:00:31.204 -- 00:00:37.229 I'd now like to introduce Dan Haemmerle, Vice President of Finance for Quest Diagnostics. 00:00:37.229 -- 00:00:39.909 Please go ahead, sir. 00:00:40.411 -- 00:00:45.795 Thank you, and good morning. I'm joined by Jim Davis, our Chairman, Chief Executive Officer 00:00:45.795 -- 00:00:49.817 and President, and Sam Samad, our Chief Financial Officer. 00:00:49.817 -- 00:00:54.760 Also joining us is Dominique Chokshi, our new Head of Investor Relations who joined Quest 00:00:54.760 -- 00:00:57.362 Diagnostics last week. 00:00:57.362 -- 00:01:02.864 During this call, we may make forward-looking statements and will discuss non-GAAP measures. 00:01:02.864 -- 00:01:07.887 We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the tables 00:01:07.887 -- 00:01:10.268 to our earnings press release. 00:01:10.268 -- 00:01:14.130 Actual results may differ materially from those projected. 00:01:14.130 -- 00:01:19.132 Risks and uncertainties that may affect Quest Diagnostics' future results include, but 00:01:19.132 -- 00:01:25.110 are not limited to, those describ...